SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-022149
Filing Date
2019-11-08
Accepted
2019-11-08 16:05:17
Documents
48
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20190930_10q.htm 10-Q 608329
2 EXHIBIT 31.1 ex_163678.htm EX-31.1 10278
3 EXHIBIT 31.2 ex_163679.htm EX-31.2 10402
4 EXHIBIT 32.1 ex_163680.htm EX-32.1 5161
5 EXHIBIT 32.2 ex_163681.htm EX-32.2 5264
  Complete submission text file 0001437749-19-022149.txt   2723754

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dffn-20190930.xml EX-101.INS 435789
7 XBRL TAXONOMY EXTENSION SCHEMA dffn-20190930.xsd EX-101.SCH 32997
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20190930_cal.xml EX-101.CAL 27091
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20190930_def.xml EX-101.DEF 205271
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20190930_lab.xml EX-101.LAB 196812
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20190930_pre.xml EX-101.PRE 224895
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 191204057
SIC: 2834 Pharmaceutical Preparations